BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//GoodLifeSci - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:GoodLifeSci
X-ORIGINAL-URL:https://goodlifesci.sidley.com
X-WR-CALDESC:Events for GoodLifeSci
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Zurich
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240904
DTEND;VALUE=DATE:20240905
DTSTAMP:20260404T085414
CREATED:20240522T164830Z
LAST-MODIFIED:20240522T164830Z
UID:1944-1725408000-1725494399@goodlifesci.sidley.com
SUMMARY:Swiss MedTech 2024: Harnessing Market Dynamics for Profitability
DESCRIPTION:Join Sidley\, ISS AG\, and Swiss Medtech in Biel for an afternoon of practical tips and interactive discussions on current issues\, including: \n\nESG and its development in the EU\nSeizing the opportunities of Artificial Intelligence\nHealth data and clinical trials\n\n \n2:00 p.m. – 6:30 p.m. CET\nFollowed by a networking drinks reception \nRSVP here. \nIndustry speakers\, regulators\, scientific experts\, and counsel will share tips and best practices for the challenges and opportunities that lie ahead for Swiss MedTech. \nWHO SHOULD ATTEND?\nExecutives\, investors\, in-house counsel\, and regulatory managers interested in and/or facing regulatory issues in Switzerland. \nFor more information\, please contact Dafne Forni Zervoudaki at +32 2 504 6202 or at dafne.fornizervoudaki@sidley.com.
URL:https://goodlifesci.sidley.com/event/swiss-medtech-2024-harnessing-market-dynamics-for-profitability/
LOCATION:Farelhaus\, Oberer Quai 12\, 2503 Biel\, Switzerland\, Switzerland
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240909
DTEND;VALUE=DATE:20240914
DTSTAMP:20260404T085414
CREATED:20240306T210249Z
LAST-MODIFIED:20240320T151628Z
UID:1835-1725840000-1726271999@goodlifesci.sidley.com
SUMMARY:Data Integrity and Governance Workshop
DESCRIPTION:Live Oak Workshops\, in collaboration with Sidley Austin\, are designed to equip you with the knowledge and critical thinking strategies that lead to success in the advancement of your GXP career. As worldwide regulatory expectations in the world of data integrity and data governance change\, our workshops prepare you with the skills necessary to interpret regulations\, guidance\, and regulatory action into simple approaches for managing your everyday GXP responsibilities with the efficiency needed to thrive. \nMonday\, September 9\, 2024 – Tuesday\, September 10\, 2024 | Ahmedabad\, India\nThursday\, September 12\, 2024 – Friday\, September 13\, 2024 | Hyderabad\, India \nSign up now to join us as we discuss\, debate\, question\, and tackle interesting regulatory case studies in the world of data integrity and data governance. \nWe are excited to now offer this worship in both Ahmedabad and Hyderabad this October. Click here to see the full two-day agenda. \nInstructors include former FDA India Office alums: \nPeter Baker\, President\, Live Oak\nFormer FDA Investigator\nPeter Baker is a GXP consultant focused on improving the quality of medicines by providing training and consulting services to organizations looking to improve the quality of their data integrity assurance strategy. Pete is a former FDA investigator whose Agency leadership included serving as Assistant Country Director (Drugs) in New Delhi\, where he performed high risk cGMP inspections of human drug manufacturers throughout India and the surrounding region\, conducted a variety of training and development exercises for manufacturers and foreign regulators\, performed joint GMP manufacturing inspections with a variety of foreign regulatory bodies\, and conducted joint investigations alongside local and regional investigation teams to facilitate harmonized regulatory actions. In 2013\, he was recognized as FDA Investigator of the year due to a significant number of FDA regulatory actions taken in India\, including product recalls and import bans based on inspections where breaches in data integrity were uncovered which affected a wide variety of products in US distribution. \nJay Jariwala\, Senior Director\, Regulatory Compliance\, Sidley\nFormer FDA Regulator\nFor over 13 years\, Jay served as an FDA regulator and leader at multiple FDA centers\, including CDER\, the Center for Devices and Radiological Health (CDRH)\, and the Office of the Commissioner\, applying the agency’s laws\, regulations\, guidance\, and other technical and administrative policies on drugs\, medical devices\, and combination products to policy development\, facility inspections\, compliance\, enforcement\, and approval processes. His FDA leadership experience includes serving as assistant country director (Drugs) and supervisory Consumer Safety officer in the agency’s India Office in New Delhi\, where he managed a team of investigators for all facility inspections conducted by the India Office and compliance follow-up. In addition to his responsibilities for resource planning and operational oversight for violative establishment inspection assessments and resulting regulatory actions\, Jay trained FDA investigators on current good manufacturing practice (CGMP) requirements — particularly data integrity and quality investigations. \nDan Roberts\, Senior Director\, Regulatory Compliance\, Sidley\nFormer FDA Investigator\nDan Roberts evaluates and assesses pharmaceutical quality systems and focuses on detecting and remediating data integrity concerns and evaluating compliant automated manufacturing processes and related computerized systems. He provides guidance and assists clients in responding to FDA-483 observations\, corresponding with regulatory agencies\, and conducting mock FDA facility audits. Dan has over 20 years of government regulatory and pharmaceutical/biopharmaceutical industry experience. He was an FDA investigator for eight years\, including two years as the primary point of contact for conducting pharmaceutical inspections at the FDA India office located at the U.S. Embassy in New Delhi. He was also the first lead investigator for the first biosimilar inspection conducted by the FDA in India. \nJim Johnson\, Partner\, Sidley\nFormer FDA Associate Chief Counsel\nJim Johnson guides life sciences companies through complex FDA compliance and enforcement matters\, including inspections\, current good manufacturing practices (GMP) requirements\, data integrity responsibilities\, product quality issues\, pharmacovigilance obligations\, and enforcement actions. Jim previously served as Associate Chief Counsel for Enforcement in the FDA’s Office of the Chief Counsel\, where he handled GMP enforcement and provided legal counsel on a range of inspectional and compliance issues to agency components\, particularly the FDA’s Office of Regulatory Affairs (ORA) and Center for Drug Evaluation and Research’s (CDER) Office of Compliance. Jim uses his extensive agency and private practice experience to assist pharmaceutical and biotechnology companies worldwide\, regularly conducting GMP assessments and investigations\, resolving warning letters and import alerts\, and appearing in front of the FDA on behalf of companies to resolve enforcement actions. \nDiscounts and Additional Information: \n\nContracts info@liveoakqa.com for groups of five or larger and receive a 10% discount code for checkout\nTea Breaks and lunch are included in the workshop.
URL:https://goodlifesci.sidley.com/event/data-integrity-and-governance-workshop/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240924
DTEND;VALUE=DATE:20240925
DTSTAMP:20260404T085414
CREATED:20240227T171412Z
LAST-MODIFIED:20240731T191635Z
UID:1817-1727136000-1727222399@goodlifesci.sidley.com
SUMMARY:Sidley Healthcare Investment Conference 2024
DESCRIPTION:Deal and investment activity remains critical to the success of life sciences and healthcare innovation. \nRSVP Here \n \n\n\n\n\n\n\n\nSidley once again brings together senior pharma\, biotech\, healthcare\, private equity\, and venture capital executives to share their perspectives on critical issues\, trends\, and opportunities. \nJoin Sidley and industry leaders from across the globe\, including from AstraZeneca\, BioCentury\, Compass Pathways\, Financial Times\, Flagship Pioneering\, IQVIA\, J.P. Morgan\, LetterOne Health\, Mestag Therapeutics\, Morgan Stanley\, Novartis\, Onex\, Permira\, Perspectum\, Rothschild & Co.\, Sofinnova Partners\, Syncona\, SV Health Investors\, and Teva for this in-person\, all-day event. Virtual attendance is available to those outside the UK. \nView the agenda here.\nView confirmed speakers here. \nPanels will include: \n\nPrivate Equity – What is the outlook for PE investment activity across Healthcare and Life Sciences? Which domains will be the “winners”?\n\nArtificial Intelligence – To what extent\, and where\, does AI represent an investment opportunity across Healthcare and Life Sciences?\n\nFireside Chat – “A Life in Pharma and Pivoting to Innovation”- A conversation with Richard Francis\, President and CEO\, Teva.\n\nA View From the Banks – Opinions\, insights\, and predictions on the market from a group of leading global healthcare dealmakers.\n\nPharma Business Development – Senior BD and biotech figures debate the M&A\, licensing\, and collaboration climate. Which therapeutic areas and geographies are garnering the most attention?\n\nVenture/Growth Capital – How are global funds investing in a more muted market? How do investees stand out? Views from leading global life sciences investors.\n\nPlease note\, due to space limitation for this event\, registrations will be reviewed and confirmed by email in due course. We strongly encourage in-person attendance and remote participation will be available to those based outside of the UK. \nFor more information or questions\, please contact lnevents@sidley.com. \nSIDLEY HEALTHCARE INVESTMENT CONFERENCE 2023 HIGHLIGHTS \n\nView the 2023 agenda\nSidley Healthcare Investment Conference 2023 Highlights Video\nA Life Well Invented: A Discussion Between Moderna Co-Founder and Chairman Noubar Afeyan and Sidley’s Robert Darwin
URL:https://goodlifesci.sidley.com/event/sidley-healthcare-investment-conference-2024/
LOCATION:The Francis Crick Institute\, 1 Midland Road\, London\, NW1 1AT\, UK\, The Francis Crick Institute\, 1 Midland Road\, London\, NW1 1AT\, United Kingdom
END:VEVENT
END:VCALENDAR